Eagle Asset Management Inc. Purchases 3,659 Shares of Catalent Inc (CTLT)
Eagle Asset Management Inc. lifted its position in shares of Catalent Inc (NASDAQ:CTLT) by 1.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 295,110 shares of the company’s stock after acquiring an additional 3,659 shares during the quarter. Eagle Asset Management Inc. owned approximately 0.24% of Catalent worth $10,358,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CTLT. Teachers Advisors LLC boosted its holdings in shares of Catalent by 3.0% during the 4th quarter. Teachers Advisors LLC now owns 164,748 shares of the company’s stock valued at $4,442,000 after acquiring an additional 4,823 shares in the last quarter. Capstone Asset Management Co. boosted its holdings in shares of Catalent by 3.4% during the 1st quarter. Capstone Asset Management Co. now owns 9,900 shares of the company’s stock valued at $280,000 after acquiring an additional 330 shares in the last quarter. Nationwide Fund Advisors boosted its holdings in shares of Catalent by 8.0% during the 1st quarter. Nationwide Fund Advisors now owns 291,103 shares of the company’s stock valued at $8,244,000 after acquiring an additional 21,540 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in shares of Catalent by 115.7% during the 1st quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock valued at $166,000 after acquiring an additional 3,136 shares in the last quarter. Finally, Glen Harbor Capital Management LLC boosted its holdings in shares of Catalent by 17.7% during the 1st quarter. Glen Harbor Capital Management LLC now owns 6,328 shares of the company’s stock valued at $179,000 after acquiring an additional 952 shares in the last quarter.
Catalent Inc (CTLT) opened at 41.67 on Thursday. Catalent Inc has a 52-week low of $21.83 and a 52-week high of $42.05. The company has a market capitalization of $5.22 billion and a price-to-earnings ratio of 47.90. The stock has a 50 day moving average price of $35.96 and a 200 day moving average price of $32.99.
Catalent (NASDAQ:CTLT) last announced its earnings results on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.08. Catalent had a net margin of 4.88% and a return on equity of 16.95%. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $547.48 million. During the same quarter last year, the firm earned $0.52 earnings per share. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. Equities research analysts forecast that Catalent Inc will post $1.60 earnings per share for the current year.
CTLT has been the topic of several recent research reports. Bank of America Corporation reissued a “buy” rating and set a $38.00 price objective (up previously from $37.00) on shares of Catalent in a report on Friday, July 21st. Zacks Investment Research raised Catalent from a “sell” rating to a “buy” rating and set a $39.00 price objective on the stock in a report on Tuesday, July 4th. BidaskClub downgraded Catalent from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. J P Morgan Chase & Co reaffirmed a “buy” rating and set a $40.00 target price on shares of Catalent in a research report on Tuesday, August 29th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $45.00 target price on shares of Catalent in a research report on Tuesday, August 29th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Catalent presently has an average rating of “Buy” and an average target price of $36.22.
In other Catalent news, SVP Christine Dolan sold 745 shares of the firm’s stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $34.85, for a total transaction of $25,963.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/07/eagle-asset-management-inc-purchases-3659-shares-of-catalent-inc-ctlt.html.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Stock Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related stocks with our FREE daily email newsletter.